ATE514729T1 - Biomaterialien die durch nukleophile reaktion auf konjugierten ungesättigten gruppen addiert sind - Google Patents

Biomaterialien die durch nukleophile reaktion auf konjugierten ungesättigten gruppen addiert sind

Info

Publication number
ATE514729T1
ATE514729T1 AT00910049T AT00910049T ATE514729T1 AT E514729 T1 ATE514729 T1 AT E514729T1 AT 00910049 T AT00910049 T AT 00910049T AT 00910049 T AT00910049 T AT 00910049T AT E514729 T1 ATE514729 T1 AT E514729T1
Authority
AT
Austria
Prior art keywords
biomaterials
unsaturated groups
added
nucleophilic reaction
conjugate unsaturated
Prior art date
Application number
AT00910049T
Other languages
English (en)
Inventor
Jeffrey Hubbell
Donald Elbert
Matthias Lutolf
Alison Pratt
Ronald Schoenmakers
Nicola Tirelli
Brent Vernon
Original Assignee
Eidgenoess Tech Hochschule
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eidgenoess Tech Hochschule, Univ Zuerich filed Critical Eidgenoess Tech Hochschule
Application granted granted Critical
Publication of ATE514729T1 publication Critical patent/ATE514729T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/916—Hydrogel compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00910049T 1999-02-01 2000-02-01 Biomaterialien die durch nukleophile reaktion auf konjugierten ungesättigten gruppen addiert sind ATE514729T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11809399P 1999-02-01 1999-02-01
PCT/US2000/002608 WO2000044808A1 (en) 1999-02-01 2000-02-01 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups

Publications (1)

Publication Number Publication Date
ATE514729T1 true ATE514729T1 (de) 2011-07-15

Family

ID=22376466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00910049T ATE514729T1 (de) 1999-02-01 2000-02-01 Biomaterialien die durch nukleophile reaktion auf konjugierten ungesättigten gruppen addiert sind

Country Status (10)

Country Link
US (1) US7744912B1 (de)
EP (2) EP2311895B1 (de)
JP (2) JP4954370B2 (de)
AT (1) ATE514729T1 (de)
AU (1) AU773914B2 (de)
CA (1) CA2359318C (de)
DK (1) DK1181323T3 (de)
ES (2) ES2368988T3 (de)
MX (1) MXPA01007777A (de)
WO (1) WO2000044808A1 (de)

Families Citing this family (143)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
PT876165E (pt) 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Composicoes de polimeros reticulados e processos para a sua utilizacao
US6872384B1 (en) 1998-02-23 2005-03-29 Life Medical Sciences, Inc. Treatment of trauma
WO2000044808A1 (en) 1999-02-01 2000-08-03 Hubbell Jeffrey A Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
KR20020000143A (ko) 1999-02-23 2002-01-04 페어슨 메디칼 인크. 외상의 치료
AUPP939299A0 (en) * 1999-03-23 1999-04-15 University Of Melbourne, The Polymer gels and methods for their preparation
EP1142596A1 (de) 2000-04-03 2001-10-10 Universiteit Gent Zusammensetzung von vernetzbaren Prepolymeren zum Gebrauch in therapeutisch aktiven, bioabbaubaren Implantaten
US7291673B2 (en) 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
AU2001275226B2 (en) * 2000-06-02 2007-06-28 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
EP1355965B1 (de) 2000-10-19 2012-09-19 Ecole Polytechnique Fédérale de Lausanne (EPFL) Verfahren zur herstellung von blockcopolymeren für multifunktionelle selbstorganisierende systeme
EP1245272A1 (de) * 2001-03-30 2002-10-02 Ucb S.A. Herstellung und Verwendung von Substraten
CA2445239C (en) * 2001-04-25 2012-08-21 Eidgenossische Technische Hochschule Zurich Drug delivery matrices to enhance wound healing
CA2445110A1 (en) * 2001-05-01 2002-11-07 Universite Du Quebec A Montreal Tridimensional biocompatible support structure for bioartificial organs and uses thereof
US7030127B2 (en) 2001-06-29 2006-04-18 Ethicon, Inc. Composition and medical devices utilizing bioabsorbable polymeric waxes
US7034037B2 (en) 2001-06-29 2006-04-25 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
US6967234B2 (en) 2002-12-18 2005-11-22 Ethicon, Inc. Alkyd-lactone copolymers for medical applications
US7288608B2 (en) * 2001-10-10 2007-10-30 Regents Of The University Of Colorado Degradable thiol-ene polymers
KR101054023B1 (ko) * 2001-11-07 2011-08-04 아이드게노시셰 테크시셰 호흐쉘 취리히 세포 내증식 및 조직 재생을 제어하기 위한 합성 매트릭스
US20070264227A1 (en) * 2001-11-07 2007-11-15 Eidgenossische Technische Hochschule Zurich Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration
WO2003054146A2 (en) 2001-11-14 2003-07-03 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
DE60225185T2 (de) * 2001-12-18 2009-02-19 Eidgenossisch Technische Hochschule Zürich Wachstumsfaktor-modifizierte proteinmatrizes zur geweberekonstruktion (tissue engineering)
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
ES2384133T3 (es) 2001-12-20 2012-06-29 Trivascular, Inc. Injerto endovascular avanzado
US7371719B2 (en) 2002-02-15 2008-05-13 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
US8282912B2 (en) 2002-03-22 2012-10-09 Kuros Biosurgery, AG Compositions for tissue augmentation
CA2478253C (en) * 2002-03-22 2011-09-20 Kuros Biosurgery Ag Composition for hard tissue augmentation
US7326426B2 (en) 2002-03-29 2008-02-05 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
US7005136B2 (en) 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
US7368125B2 (en) 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
US7026374B2 (en) 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
US7101566B2 (en) 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
US7534761B1 (en) 2002-08-21 2009-05-19 North Western University Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
WO2004046167A2 (en) 2002-11-14 2004-06-03 Northwestern University Synthesis and self-assembly of abc triblock bola peptide
WO2004046200A1 (ja) 2002-11-21 2004-06-03 Chugai Seiyaku Kabushiki Kaisha 薬物徐放担体
US6872799B2 (en) 2002-12-18 2005-03-29 Ethicon, Inc. Functionalized polymers for medical applications
EP1581260B1 (de) 2002-12-31 2014-09-17 Nektar Therapeutics Polymerreagentien mit einer keto- oder verwandten funktion
JP4837553B2 (ja) 2003-02-11 2011-12-14 ノースウエスタン ユニバーシティ ナノ結晶表面被膜の方法及び材料ならびにその上へのペプチド両親媒性物質ナノ繊維の付着物
US7632291B2 (en) 2003-06-13 2009-12-15 Trivascular2, Inc. Inflatable implant
US7217294B2 (en) 2003-08-20 2007-05-15 Histogenics Corp. Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and method for use thereof
JP4742491B2 (ja) * 2003-09-30 2011-08-10 株式会社豊田中央研究所 細胞着床方法及び細胞組織作製方法
AU2003267747A1 (en) * 2003-10-14 2005-05-05 Ramesh Varada Bapat Sterile gelling agents
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
US20050119762A1 (en) 2003-11-03 2005-06-02 Peter Zilla Hydrogel providing cell-specific ingrowth
JP4745826B2 (ja) 2003-11-14 2011-08-10 中外製薬株式会社 架橋多糖微粒子およびその製造方法
CN1905892A (zh) 2003-12-05 2007-01-31 西北大学 自组装的肽两亲物和用于生长因子传递的相关方法
KR20070004561A (ko) 2003-12-05 2007-01-09 노오쓰웨스턴 유니버시티 분지형 펩티드 친양매성 화합물들, 그들의 관련된 에피토프화합물들 및 자가조립된 구조들
EP1710304A4 (de) * 2003-12-24 2008-01-16 Shionogi & Co Verfahren zur herstellung von polymer-verbund aus protein
CA2552649A1 (en) * 2004-01-07 2005-07-28 Boston Scientific Santa Rosa Corporation Methods, compositions, and devices for embolizing body lumens
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
KR100974733B1 (ko) 2004-04-28 2010-08-06 안지오디바이스 인터내셔널 게엠베하 가교된 생합성물질을 형성하기 위한 조성물 및 시스템, 및이와 관련된 제조 및 사용 방법
US7445630B2 (en) 2004-05-05 2008-11-04 Direct Flow Medical, Inc. Method of in situ formation of translumenally deployable heart valve support
ES2299776T3 (es) 2004-06-16 2008-06-01 Straumann Holding Ag Membrana de barrera.
US7282584B2 (en) 2004-06-16 2007-10-16 Straumann Holding Ag Methylene blue
EP2111872B1 (de) * 2004-07-05 2020-12-23 Ascendis Pharma GmbH Hydrogel-konjugate
EP1625856A1 (de) * 2004-08-13 2006-02-15 Complex Biosystems GmbH Hydrogel Polymer Prodroge Konjugate
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
EP1784145B1 (de) 2004-08-30 2011-08-10 Neville Alleyne Implantat zur behandlung von bändern und sehnen
CA2578113A1 (en) 2004-08-30 2006-03-09 Spineovations, Inc. Method of treating spinal internal disk derangement
CA2581093C (en) 2004-09-17 2014-11-18 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
EP1862170B1 (de) 2004-12-10 2012-03-14 Straumann Holding AG Emailleformulierung mit Amelogenin
AU2005315253B2 (en) 2004-12-10 2011-07-21 Straumann Holding Ag Protein formulation
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
CA2598251A1 (en) 2005-03-04 2006-09-14 Northwestern University Angiogenic heparin binding peptide amphiphiles
US20060222596A1 (en) 2005-04-01 2006-10-05 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US9505867B2 (en) 2005-05-31 2016-11-29 Ecole Polytechmique Fédérale De Lausanne Triblock copolymers for cytoplasmic delivery of gene-based drugs
CA2610669A1 (en) 2005-06-07 2006-12-14 Direct Flow Medical, Inc. Stentless aortic valve replacement with high radial strength
EP2053066A1 (de) 2005-09-16 2009-04-29 Straumann Holding AG Verwendung von Methylenblau als Polymerisationsinhibitor
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
ES2385895T3 (es) * 2006-02-20 2012-08-02 Straumann Holding Ag Material en gránulos y matriz
WO2007108775A1 (en) * 2006-03-21 2007-09-27 Agency For Science, Technology And Research Cell-adhesive polyelectrolyte material for use as membrane and coating
WO2007128059A1 (en) * 2006-05-05 2007-11-15 The University Of Sydney Bis-pyridinium compounds
US7935144B2 (en) 2006-10-19 2011-05-03 Direct Flow Medical, Inc. Profile reduction of valve implant
US8133213B2 (en) 2006-10-19 2012-03-13 Direct Flow Medical, Inc. Catheter guidance through a calcified aortic valve
WO2008051864A2 (en) * 2006-10-24 2008-05-02 Neville Alleyne Method of treating spinal internal disk derangement
AR064286A1 (es) 2006-12-13 2009-03-25 Quiceno Gomez Alexandra Lorena Produccion de dispositivos oftalmicos basados en la polimerizacion por crecimiento escalonado fotoinducida
PL2124831T3 (pl) 2007-03-15 2017-03-31 Ortho-Space Ltd. Urządzenia protetyczne
DK2136850T3 (da) * 2007-04-13 2012-04-10 Kuros Biosurgery Ag Polymervævforsegling
US8076295B2 (en) 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
JP5443976B2 (ja) 2007-05-01 2014-03-19 国立大学法人 東京医科歯科大学 化学架橋ヒアルロン酸誘導体を含むハイブリッドゲルおよびそれを用いた医薬組成物
EP2014256A1 (de) 2007-07-12 2009-01-14 Straumann Holding AG Verbundmaterial zur Knochenreparatur
EP3075355A1 (de) 2007-08-23 2016-10-05 Direct Flow Medical, Inc. Transluminale implantierbare herzklappe mit geformter stütze
BRPI0817488A2 (pt) 2007-10-04 2017-05-16 Trivascular Inc enxerto vascular modular para perfil percutâneo baixo
JP2012512812A (ja) 2007-12-28 2012-06-07 クロス・バイオサージェリー・アクチェンゲゼルシャフト フィブリンフォームに組込まれたｐｄｇｆ融合タンパク質
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
DE202008005131U1 (de) 2008-04-14 2008-08-28 Eidgenössische Technische Hochschule Zürich Synthetische Matrix für das gesteuerte Einwachsen von Zellen und Geweberegeneration
WO2010027471A2 (en) 2008-09-04 2010-03-11 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
JP5814793B2 (ja) 2008-11-25 2015-11-17 エコール ポリテクニク フェデラル ド ローザンヌ（エーペーエフエル） ブロックコポリマーおよびその使用
AU2010236584A1 (en) 2009-04-13 2011-11-10 Northwestern University Novel peptide-based scaffolds for cartilage regeneration and methods for their use
NZ598021A (en) 2009-07-31 2014-05-30 Sanofi Aventis Deutschland Prodrugs comprising an insulin linker conjugate
MA33466B1 (fr) 2009-07-31 2012-07-03 Sanofi Aventis Deutschland Composition d'insuline à longue duree d'action
US10058837B2 (en) 2009-08-28 2018-08-28 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
SG182547A1 (en) * 2010-01-13 2012-08-30 Georg Bischof Composition for producing a temporary intestinal occlusion
US8962823B2 (en) 2010-01-19 2015-02-24 Organoclick Ab Heterogeneous thiol-ene click modifications of solid polysaccharide-based materials
US9198568B2 (en) 2010-03-04 2015-12-01 The General Hospital Corporation Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production
EP2380920A1 (de) 2010-04-22 2011-10-26 QGel SA Hydrogelvorstufenformulierung und Herstellungsverfahren dafür
US9603708B2 (en) 2010-05-19 2017-03-28 Dfm, Llc Low crossing profile delivery catheter for cardiovascular prosthetic implant
US20130224880A1 (en) 2011-05-27 2013-08-29 Ptm Biolabs, Inc. Reagents and methods for detecting protein crotonylation
CN102375065A (zh) * 2010-05-27 2012-03-14 杭州景杰生物科技有限公司 蛋白质中赖氨酸丁烯酰化的鉴定方法及其亲和试剂研制
DK2590595T3 (en) 2010-07-09 2015-12-07 Highlife Sas Transcatheter atrioventricular heart valve prosthesis
DE102010034331A1 (de) * 2010-08-14 2012-02-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Polymer-gestützte Kultursysteme
EP2438930A1 (de) 2010-09-17 2012-04-11 Sanofi-Aventis Deutschland GmbH Prodrug mit einem exendinbindenden Konjugat
US8518440B2 (en) * 2010-12-21 2013-08-27 Confluent Surgical, Inc. Biodegradable osmotic pump implant for drug delivery
WO2012103445A2 (en) 2011-01-28 2012-08-02 The Regents Of The University Of Colorado, A Body Corporate Convalently cross linked hydrogels and methods of making and using same
EP2686027B1 (de) 2011-03-16 2021-05-05 Kuros Biosurgery AG Pharmazeutische formulierung zur verwendung für die wirbelsäulenfusion
CN103687622A (zh) 2011-06-16 2014-03-26 香港科技大学 含有多个乙烯砜的分子
US9289307B2 (en) 2011-10-18 2016-03-22 Ortho-Space Ltd. Prosthetic devices and methods for using same
US9988433B2 (en) 2013-03-14 2018-06-05 Mosaic Biosciences, Inc. Covalent modification of biological macromolecules
WO2013116791A1 (en) 2012-02-02 2013-08-08 Mosaic Biosciences, Inc. Biomaterials for delivery of blood extracts and methods of using same
US9993328B2 (en) 2012-04-03 2018-06-12 Trivascular, Inc. Advanced kink resistant stent graft
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9445897B2 (en) 2012-05-01 2016-09-20 Direct Flow Medical, Inc. Prosthetic implant delivery device with introducer catheter
US9879062B2 (en) 2012-07-03 2018-01-30 Ecole Polytechnique Federale De Lausanne Protein-binding peptide isolated from placenta growth factor
US9540428B2 (en) 2012-07-03 2017-01-10 Ecole Polytechnique Federale De Lausanne (Epfl) Extracellular matrix heparin-binding domains
US9395468B2 (en) 2012-08-27 2016-07-19 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
EP2906144B1 (de) 2012-10-10 2017-08-02 TriVascular, Inc. Endovaskuläres transplantat für aneurysmen mit beteiligung von grossen verzweigten gefässen
WO2014070973A1 (en) * 2012-11-02 2014-05-08 Board Of Supervisors Of Louisiana State University And Agricural And Mechanical College Thiol acrylate nanocomposite foams
WO2014190317A2 (en) 2013-05-24 2014-11-27 Cedars-Sinai Medical Center Left atrial appendage occlusion devices and methods
US20160114081A1 (en) * 2013-05-31 2016-04-28 Francesco Serino Methods and compositions for blood vessel tissue repair and engineering
US10711106B2 (en) 2013-07-25 2020-07-14 The University Of Chicago High aspect ratio nanofibril materials
US11123205B2 (en) 2013-09-24 2021-09-21 Trivascular, Inc. Tandem modular endograft
WO2015073758A1 (en) 2013-11-15 2015-05-21 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US9873769B2 (en) 2014-07-10 2018-01-23 Cambridge Polymer Group, Inc. Thiolated PEG-PVA hydrogels
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2016094533A1 (en) 2014-12-09 2016-06-16 Ocular Dynamics, Llc Medical device coating with a biocompatible layer
CA2973727A1 (en) 2015-01-16 2016-07-21 Spineovations, Inc. Method of treating spinal disk
EP3256167B1 (de) 2015-02-09 2020-11-11 Mosaic Biosciences, Inc. Abbaubare thiol-en-polymere und verfahren zur herstellung davon
US10959761B2 (en) 2015-09-18 2021-03-30 Ortho-Space Ltd. Intramedullary fixated subacromial spacers
US11199776B2 (en) 2016-07-27 2021-12-14 Toray Industries, Inc. Resin composition
US11045981B2 (en) 2017-01-30 2021-06-29 Ortho-Space Ltd. Processing machine and methods for processing dip-molded articles
FR3078261B1 (fr) * 2018-02-28 2020-02-07 Universite de Bordeaux Hydrogel pour stimuler la neurotisation, l'osteogenese et l'angiogenese
US20220075098A1 (en) * 2018-12-19 2022-03-10 Tangible Science, Inc. Systems and methods of treating a hydrogel-coated medical device
EP3918324A2 (de) 2019-01-30 2021-12-08 Ventana Medical Systems, Inc. Kalibrierungsschieber für digitale pathologie
EP4031185A2 (de) * 2019-09-21 2022-07-27 Ixaka France Dmso-freie synthese von oligopeptid-modifizierten poly(beta-aminoestern) und deren verwendung in nanoteilchenabgabesystemen
WO2021068025A1 (en) * 2019-10-09 2021-04-15 Phoenix Eagle Company Pty Ltd Enhancement and stabilisation of proteolytic activity of proteases
KR20220011903A (ko) 2020-07-22 2022-02-03 삼성전자주식회사 식기 세척기
KR102425509B1 (ko) * 2020-10-13 2022-07-27 고려대학교 산학협력단 줄기세포의 거동 조절용 나노코일-기판 복합체, 이의 제조방법 및 이를 이용한 줄기세포의 부착 및 분화 조절 방법
WO2024250012A2 (en) 2023-06-02 2024-12-05 33 Medical, Inc. Compositions for treatment of discogenic pain, and processes for making and using the same
EP4616875A1 (de) 2024-03-12 2025-09-17 Novonexile AG Halb-interpenetrierende polymernetzwerke

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA992105A (en) 1970-03-26 1976-06-29 Exxon Research And Engineering Company Polythioethers formed by anionic ring opening of episulfides
JPS6198734A (ja) * 1984-10-19 1986-05-17 Showa Denko Kk 硬化性組成物
US4618400A (en) 1984-12-28 1986-10-21 Shell Oil Company Wastepaper deinking process
US4711903A (en) * 1986-01-31 1987-12-08 G. D. Searle & Co. Phenolic thioethers as inhibitors of 5-lipoxygenase
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5247041A (en) * 1989-02-22 1993-09-21 Toray Industries, Inc. Thiol methacrylate or acrylate resin obtained by polymerizing a thiol methacrylate or acrylate compound
US5268305A (en) * 1989-06-15 1993-12-07 Biocircuits Corporation Multi-optical detection system
US5330911A (en) 1989-09-28 1994-07-19 Board Of Regents, The University Of Texas System Surfaces having desirable cell adhesive effects
US5852182A (en) 1990-01-11 1998-12-22 Isis Pharmaceuticals Inc. Thiol-derivatized oligonucleosides
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5529914A (en) 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
AU4406793A (en) 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US5292514A (en) * 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
JP4091654B2 (ja) 1992-08-25 2008-05-28 ジー．ディー．サール、リミテッド、ライアビリティ、カンパニー レトロウイルスプロテアーゼ阻害剤として有用なスルホニルアルカノイルアミノヒドロキシエチルアミノスルホンアミド
WO1994005282A1 (en) 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
US5321095A (en) 1993-02-02 1994-06-14 Enzon, Inc. Azlactone activated polyalkylene oxides
AU673057B2 (en) * 1993-02-22 1996-10-24 Abraxis Bioscience, Llc Methods for (in vivo) delivery of biologics and compositionsuseful therefor
US5428014A (en) 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
JPH0848770A (ja) * 1994-06-03 1996-02-20 Toyo Ink Mfg Co Ltd 液状樹脂組成物、その製造方法、および硬化性樹脂組成物
JPH0892369A (ja) * 1994-07-29 1996-04-09 Toyo Ink Mfg Co Ltd 硬化性液状樹脂組成物およびその硬化物の製造方法
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5702717A (en) 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
AU7566396A (en) 1995-11-16 1997-06-05 Boehringer Mannheim Gmbh Process for the preparation of peptides by way of streptavidin fusion proteins
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
PT876165E (pt) 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Composicoes de polimeros reticulados e processos para a sua utilizacao
US5914182A (en) 1996-06-03 1999-06-22 Gore Hybrid Technologies, Inc. Materials and methods for the immobilization of bioactive species onto polymeric substrates
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US6258351B1 (en) 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
JP2001508783A (ja) 1997-01-29 2001-07-03 ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー Ｐｅｇ化法
DE19705963A1 (de) 1997-02-17 1998-08-20 Hoechst Ag Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung
ES2211033T3 (es) 1998-01-07 2004-07-01 Debio Recherche Pharmaceutique S.A. Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos.
US5958874A (en) 1998-02-18 1999-09-28 The Research Foundation Of State University Of New York Recombinant fibronectin-based extracellular matrix for wound healing
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
WO2000044808A1 (en) 1999-02-01 2000-08-03 Hubbell Jeffrey A Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
PE20010288A1 (es) 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
EP1355965B1 (de) 2000-10-19 2012-09-19 Ecole Polytechnique Fédérale de Lausanne (EPFL) Verfahren zur herstellung von blockcopolymeren für multifunktionelle selbstorganisierende systeme
EP1379133A2 (de) 2001-03-20 2004-01-14 Eidgenössische Technische Hochschule Zürich Zweistufiges verfahren zur verarbeitung von wärmeempfindlichen polymeren als biomaterialien
KR101054023B1 (ko) 2001-11-07 2011-08-04 아이드게노시셰 테크시셰 호흐쉘 취리히 세포 내증식 및 조직 재생을 제어하기 위한 합성 매트릭스

Also Published As

Publication number Publication date
ES2632564T3 (es) 2017-09-14
US7744912B1 (en) 2010-06-29
DK1181323T3 (da) 2011-10-17
AU3220400A (en) 2000-08-18
WO2000044808A1 (en) 2000-08-03
AU773914B2 (en) 2004-06-10
ES2368988T3 (es) 2011-11-24
JP4954370B2 (ja) 2012-06-13
CA2359318A1 (en) 2000-08-03
EP2311895B1 (de) 2017-04-12
JP2012101095A (ja) 2012-05-31
CA2359318C (en) 2009-06-30
EP1181323A4 (de) 2005-04-20
JP2002535108A (ja) 2002-10-22
EP2311895A1 (de) 2011-04-20
EP1181323A1 (de) 2002-02-27
EP1181323B1 (de) 2011-06-29
MXPA01007777A (es) 2003-10-06

Similar Documents

Publication Publication Date Title
ATE514729T1 (de) Biomaterialien die durch nukleophile reaktion auf konjugierten ungesättigten gruppen addiert sind
BR9508031A (pt) Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
BR9802570A (pt) Caixa de câmbio
ATE397952T1 (de) Medizinische vorrichtungen
CH0788360H1 (de) Boronsäure-und-esterverbindungen, deren synthese und verwendungen.
PT897904E (pt) 2-metoxibenzofenonas fungicidas
ATE225371T1 (de) Vernetzte hyaluronsäure und ihre medizinischen verwendungen
BR9804214A (pt) Compostos.
ATE471160T1 (de) Therapeutische polyanhydride verbindungen zur arzneimittelabgabe
BR0111520A (pt) Tiazina oxazolidinona usada como agente antimicrobiano
ES2167436T3 (es) Tabletas de flubendazol masticables para animales de compañia.
ZA200007597B (en) Process for the production of an aqueous monoester peroxycarboxylic acid solution, the solution obtainable by this process, and its use as disinfectant.
ATE282666T1 (de) Harze verwendbar als nassfestigkeitsmittel und krepphilfsmittel, ihre herstellung und ihre verwendung
DE69632643D1 (de) Verwendungen von nukleinsäuren die ein retrovirus aus schweinen entnommen sind
PT971922E (pt) Compostos de tetra-hidropirido
BR0105906A (pt) Dispositivo de ativação
DE60029084D1 (de) Neue depsipeptid-verbindung
FR2801901B1 (fr) Procede de transformation de matieres organiques, en particulier saccharidiques, comprenant une etape d'oxydation enzymatique en presence de ruthenium ou palladium
DE50004236D1 (de) Verfahren zur Herstellung von 1,1,4,4-Tetramethoxybuten-2
NL1012219A1 (nl) Werkwijze voor de polymersitie van overzadigde polyalkylpiperidinen.
DE60033542D1 (de) Zusammensetzungen für die elektroporation
EP0551844A3 (de)
DE60317303D1 (de) Hemoglobin Konjugate
DE60028593D1 (de) Perkutane absorptionsbeschleuniger für die elektroporation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1181323

Country of ref document: EP